ClinConnect ClinConnect Logo
Search / Trial NCT07053605

Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen

Launched by NORTHERN JIANGSU PEOPLE'S HOSPITAL · Jul 1, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Laparoscopy Resection Of Splenic Artery Aneurysm Immune Function Hemodynamics

ClinConnect Summary

This clinical study is looking at a surgical treatment for people who have a splenic artery aneurysm, which is a bulge or swelling in the artery that supplies blood to the spleen. The surgery is done using small cuts and a camera (called laparoscopic surgery) to remove the aneurysm while keeping the spleen intact. Researchers want to see how this surgery affects important body functions like the immune system and blood flow through nearby veins and arteries. The goal is to understand if these changes can help improve the patient’s health after surgery.

People who might join this study are adults aged 65 to 74 who have specific types of splenic artery aneurysms—either ones larger than 2 cm, ones that have burst, or ones that are growing quickly. To be eligible, the aneurysm must be in the main part of the splenic artery, and participants need to agree to join the study. This study is currently looking for volunteers. People with certain health problems like cancer, liver disease with high blood pressure in the veins, recent stomach ulcers, bleeding strokes, pregnancy, blood disorders, uncontrolled high blood pressure, or HIV are not eligible. If you join, you can expect to have the laparoscopic surgery and follow-up tests to monitor how your body responds after the procedure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Asymptomatic splenic artery aneurysms with a diameter\>2 cm,ruptured splenic artery aneurysms,and splenic artery aneurysms with a diameter increase\>0.5 cm/year.
  • Aneurysm located in the main trunk of the splenic artery. Informed consent to participate in the study.
  • Exclusion Criteria:
  • Patients with malignancies Hepatic cirrhosis with portal hypertension peptic ulcer disease Recent peptic ulcer disease History of Hemorrhagic stroke Pregnancy hematological diseases Uncontrolled Hypertension Human immunodeficiency virus (HIV) infection

About Northern Jiangsu People's Hospital

Northern Jiangsu People's Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. Located in Northern Jiangsu, China, the hospital is renowned for its comprehensive clinical services and commitment to innovative medical practices. As a clinical trial sponsor, the hospital collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at evaluating new treatments and interventions. With a focus on patient safety and ethical standards, Northern Jiangsu People's Hospital strives to contribute to the global medical community by enhancing evidence-based practices and fostering advancements in healthcare.

Locations

Yangzhou, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Guo-Qing Jiang

Study Chair

Clinical Medical College, Yangzhou University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported